-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Prelude Therapeutics Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2024.
- Prelude Therapeutics Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $426K, a 53.2% increase year-over-year.
- Prelude Therapeutics Inc annual Depreciation, Depletion and Amortization for 2023 was $1.17M, a 11.7% decline from 2022.
- Prelude Therapeutics Inc annual Depreciation, Depletion and Amortization for 2022 was $1.32M, a 44.7% increase from 2021.
- Prelude Therapeutics Inc annual Depreciation, Depletion and Amortization for 2021 was $915K, a 68.8% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)